Your browser is no longer supported. Please, upgrade your browser.
NURO NeuroMetrix, Inc. monthly Stock Chart
NURO [NASD]
NeuroMetrix, Inc.
Index- P/E- EPS (ttm)-3.26 Insider Own0.70% Shs Outstand3.79M Perf Week-3.05%
Market Cap5.82M Forward P/E- EPS next Y- Insider Trans56.51% Shs Float3.75M Perf Month-8.62%
Income-4.00M PEG- EPS next Q- Inst Own1.50% Short Float4.86% Perf Quarter-22.06%
Sales7.30M P/S0.80 EPS this Y- Inst Trans34.23% Short Ratio0.70 Perf Half Y-34.30%
Book/sh1.42 P/B1.12 EPS next Y- ROA-37.60% Target Price- Perf Year-40.91%
Cash/sh1.34 P/C1.19 EPS next 5Y15.00% ROE-71.00% 52W Range0.81 - 6.20 Perf YTD-63.02%
Dividend- P/FCF- EPS past 5Y62.00% ROI-152.70% 52W High-74.35% Beta2.88
Dividend %- Quick Ratio2.60 Sales past 5Y11.00% Gross Margin63.50% 52W Low95.81% ATR0.11
Employees23 Current Ratio3.10 Sales Q/Q-4.80% Oper. Margin-38.30% RSI (14)46.02 Volatility5.63% 6.22%
OptionableNo Debt/Eq0.00 EPS Q/Q95.30% Profit Margin-38.50% Rel Volume0.21 Prev Close1.50
ShortableYes LT Debt/Eq0.00 EarningsOct 22 BMO Payout- Avg Volume260.51K Price1.59
Recom2.00 SMA20-4.49% SMA50-5.00% SMA200-24.08% Volume54,717 Change6.00%
Oct-20-17Reiterated H.C. Wainwright Buy $10 → $3
Jun-28-16Initiated Rodman & Renshaw Buy $4.50
Sep-11-15Initiated Maxim Group Buy $2
Feb-27-12Initiated Dawson James Buy $3
Oct-22-20 07:00AM  
Oct-15-20 11:00AM  
Sep-22-20 07:00AM  
Sep-21-20 01:00PM  
Sep-04-20 07:00AM  
Sep-01-20 01:00PM  
Aug-20-20 02:11PM  
Aug-10-20 10:00AM  
Jul-23-20 07:00AM  
Jul-16-20 03:14PM  
Jul-09-20 01:00PM  
Jun-25-20 01:00PM  
Jun-10-20 06:30PM  
01:00PM  
Apr-23-20 07:00AM  
06:00AM  
Apr-16-20 01:30PM  
11:00AM  
Apr-15-20 09:17AM  
Apr-10-20 01:43PM  
Mar-11-20 11:00AM  
Mar-05-20 12:14PM  
Feb-25-20 01:58PM  
Feb-20-20 09:19AM  
Jan-30-20 04:43AM  
Jan-27-20 07:00AM  
Jan-22-20 10:43AM  
Jan-17-20 12:49PM  
Jan-06-20 01:15PM  
06:32AM  
Dec-06-19 09:25AM  
Nov-18-19 11:50AM  
Nov-13-19 09:07AM  
Oct-25-19 08:45AM  
Oct-18-19 07:07AM  
Oct-17-19 07:00AM  
Oct-15-19 11:00AM  
Oct-10-19 11:00AM  
Jul-21-19 11:30PM  
Jul-18-19 07:00AM  
06:00AM  
Jul-15-19 09:15AM  
Jul-11-19 01:15PM  
10:31AM  
Jun-28-19 07:32AM  
Jun-27-19 07:00AM  
May-21-19 01:00PM  
May-07-19 01:00PM  
May-01-19 11:07PM  
Apr-28-19 10:05AM  
Apr-25-19 07:00AM  
06:00AM  
Apr-18-19 10:33AM  
Apr-17-19 11:00AM  
Apr-12-19 10:30AM  
Mar-07-19 11:45AM  
Jan-29-19 01:00PM  
Jan-28-19 11:55AM  
08:24AM  
Jan-24-19 07:00AM  
Jan-22-19 01:00PM  
Jan-16-19 01:00PM  
Jan-15-19 02:00PM  
Jan-08-19 01:30PM  
Jan-07-19 07:00AM  
Dec-27-18 01:30PM  
Dec-26-18 02:12PM  
Dec-19-18 01:30PM  
Dec-12-18 01:22PM  
06:55AM  
Dec-11-18 01:30PM  
Nov-28-18 11:00AM  
Nov-20-18 10:41AM  
Nov-15-18 12:50PM  
08:15AM  
Oct-31-18 11:00AM  
Oct-19-18 11:43AM  
Oct-18-18 11:00AM  
Oct-17-18 07:00AM  
06:00AM  
Oct-10-18 11:00AM  
Oct-05-18 02:12PM  
Oct-02-18 11:00AM  
Sep-25-18 10:00AM  
Sep-20-18 01:00PM  
Sep-04-18 02:00PM  
Aug-29-18 01:00PM  
Aug-28-18 11:00AM  
Aug-27-18 01:30PM  
Aug-23-18 01:30PM  
Aug-21-18 02:30PM  
Jul-25-18 07:05AM  
Jul-21-18 12:48AM  
Jul-19-18 07:00AM  
06:00AM  
Jul-12-18 11:00AM  
Jul-05-18 01:00PM  
Jun-28-18 12:27PM  
Jun-26-18 11:00AM  
Jun-21-18 11:00AM  
NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; ADVANCE system, a platform for the performance of traditional nerve conduction studies; and SENSUS, a pain therapy device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain. The company offers its products to consumers, retail merchandisers, direct response TV promoters, health care professionals, managed care organizations, endocrinologists, podiatrists, physicians, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neurosurgeons. It operates in the United States, Europe, Japan, China, the Middle East, and Mexico. The company has a strategic collaboration with GlaxoSmithKline. NeuroMetrix, Inc. was founded in 1996 and is based in Woburn, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gozani ShaiPresident & CEOJun 11Buy1.841,0001,84024,630Jun 11 05:12 PM
Gozani ShaiPresident & CEOMay 21Buy2.335001,16523,630May 21 03:50 PM
Gozani ShaiPresident & CEOMay 14Buy2.181,0002,18023,130May 14 04:11 PM
Gozani ShaiPresident & CEOMay 13Buy2.4625061522,130May 13 04:27 PM
Gozani ShaiPresident & CEOMay 12Buy2.285001,14021,880May 12 08:20 PM
Gozani ShaiPresident & CEOMay 08Buy2.071,0002,07021,380May 08 04:02 PM
Gozani ShaiPresident & CEOMay 07Buy2.111,0002,11020,380May 07 04:33 PM
Gozani ShaiPresident & CEOMay 06Buy2.031,0002,03019,380May 06 05:14 PM
Gozani ShaiPresident & CEOMay 05Buy2.291,0002,29018,380May 06 10:39 AM
Gozani ShaiPresident & CEOApr 30Buy2.462,0004,92017,380Apr 30 05:02 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.